Apimeds Pharmaceuticals US APUS Estimates

NYSE APUS
$5.00 -1.39 (-21.75%)
As of: Sep 29, 2026 · 3:59 PM EDT

Analyst Estimates

No estimate data available No analyst coverage has been matched to this ticker yet.

Apimeds Pharmaceuticals US, Inc. Estimates API

Pull Wall Street consensus for Apimeds Pharmaceuticals US, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=APUS&mode=revenue&api_key=YOUR_API_KEY